Azitra (AZTR) vs InMed Pharmaceuticals (INM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Azitra is the larger company by market cap ($7.9 million vs $7.5 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AZTR | INM |
|---|---|---|
| Share price | $0.1299 | $1.36 |
| Market cap | $7.87M | $7.47M |
| 1-day change | -1.59% | +2.26% |
| EPS (TTM) | $-0.28 | $-2.89 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.09 | $2.33 |
| 52-week low | $0.10 | $0.575 |
| Distance from 52-week high | -88.08% | -41.63% |
| Analyst consensus | buy | — |
| Avg. price target upside | +415.78% | — |
| Average volume | 1.68M | 928.44K |
| Shares outstanding | 60.60M | 5.49M |
| Employees | 13 | 6 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Azitra
AZTR stock →Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States. The company develops ATR-04, a genetically modified strain of S.
Health Care · Biotechnology: Pharmaceutical Preparations · 13 employees
About InMed Pharmaceuticals
INM stock →InMed Pharmaceuticals Inc. operates as a pharmaceutical drug development company in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 6 employees
AZTR vs INM FAQ
Which is bigger, Azitra or InMed Pharmaceuticals?
Azitra (AZTR) is larger, with a market capitalization of $7.87M compared with $7.47M for InMed Pharmaceuticals (INM).
Are Azitra and InMed Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.